NASDAQ

TransCode Therapeutics Inc

---
RNAZ医療関連
  • 15分ディレイ株価

TransCode Therapeutics Incの株価・株式情報

株価詳細値

マネックス証券ロゴこの銘柄はマネックス証券で
期間を保存

企業概要

TransCode Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative drugs for treating metastatic disease. Co.'s lead therapeutic candidate, TTX-MC138, is an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive.

参考指標

  • 時価総額
    715.00千ドル(03/18)
  • 発行済株式数
    1,056,372(03/19)
  • PER(実績)
    ---(--:--)
  • PBR(実績)
    ---(--:--)
  • EPS(実績)
    ---(----/--)
  • BPS(実績)
    ---(----/--)
  • 52週高値
    9.80(23/04/05)
  • 52週安値
    0.12(24/01/10)